Effects of phenytoin and Echinacea purpurea extract on proliferation and apoptosis of mouse embryonic palatal mesenchymal cells

Journal of Cellular Biochemistry

Volumn 112, Issue 5, 2011, Pages 1311-1317

  Hu, Xiao ^a   Chen, Zhenguo ^a   Mao, Xiaoyan ^a   Tang, Shijie ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

cleft palate; Echinacea purpurea extract; mouse embryonic palatal mesenchymal cells; phenytoin

Indexed keywords

BROXURIDINE; CHOLECYSTOKININ OCTAPEPTIDE; ECHINACEA PURPUREA EXTRACT; PHENYTOIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL LABELING; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CLEFT PALATE; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYO; EMBRYO DEVELOPMENT; FLOW CYTOMETRY; MESENCHYME CELL; MOUSE; NICK END LABELING; NONHUMAN; PALATE; PRIORITY JOURNAL; PROTEIN DETERMINATION; TERATOGENESIS;

ANIMALS; ANTICONVULSANTS; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CLEFT PALATE; CYTOPROTECTION; ECHINACEA; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; PALATE; PHENYTOIN; PLANT EXTRACTS; TERATOGENS;

ECHINACEA PURPUREA;

EID: 79953679576     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23044     Document Type: Article

References (45)

1. Barrett B,. 2003. Medicinal properties of Echinacea: A critical review. Phytomedicine 10: 66-86. (Pubitemid 36262210)
2. Benson JM, Pokorny AJ, Rhule A, Wenner CA, Kandhi V, Cech NB, Shepherd DM,. 2010. Echinacea purpurea extracts modulate murine dendritic cell fate and function. Food Chem Toxicol 48: 1170-1177.
3. Borchers AT, Keen CL, Stern JS, Gershwin ME,. 2000. Inïammation and native American medicine: The role of botanicals. Am J Clin Nutr 72: 339-347. (Pubitemid 30620636)
4. Burger RA, Torres AR, Warren RP, Caldwell VD, Hughes BG,. 1997. Echinacea-induced cytokine production by human macrophages. Int J Immunopharmacol 19: 371-379. (Pubitemid 28137503)
5. Centers for Disease Control and Prevention (CDC). 2004. Spina bifida and anencephaly before and after folic acid mandate-United States, 1995-1996 and 1999-2000. Morb Mortal Wkly Rep 53: 362-365.
6. Cuervo R, Valencia C, Chandraratna RA, Covarrubias L,. 2002. Programmed cell death is required for palate shelf fusion and is regulated by retinoic acid. Dev Biol 245: 145-156. (Pubitemid 34461810)
7. Dhulipala VC, Hanumegowda UM, Balasubramanian G, Reddy CS,. 2004. Relevance of the palatal protein kinase A pathway to the pathogenesis of cleft palate by secalonic acid D in mice. Toxicol Appl Pharmacol 194: 270-279. (Pubitemid 38175289)
8. Dudas M, Li WY, Kim J, Yang A, Kaartinen V,. 2007. Palatal fusion-where do the midline cells go? A review on cleft palate, a major human birth defect. Acta Histochem 109: 1-14. (Pubitemid 46188337)
9. Edison RJ, Muenke M,. 2004. Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med 350: 1579-1582. (Pubitemid 38477791)
10. Ernst E,. 2002. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 136: 42-53. (Pubitemid 34038696)
11. Goldman AS, Baker MK, Piddington R, Herold R,. 1983. Inhibition of programmed cell death in mouse embryonic palate in vitro by cortisol and phenytoin: Receptor involvement and requirement of protein synthesis. Proc Soc Exp Biol Med 174: 239-243. (Pubitemid 14228188)
12. Han J, Xiao Y, Lin J, Li Y,. 2006. PDGF-C controls proliferation and is down-regulated by retinoic acid in mouse embryonic palatal mesenchymal cells. Birth Defects Res B Dev Reprod Toxicol 77: 438-444. (Pubitemid 44657368)
13. Hanumegowda UM, Judy BM, Welshons WV, Reddy CS,. 2002. Selective inhibition of murine palatal mesenchymal cell proliferation in vitro by secalonic acid D. Toxicol Sci 66: 159-165. (Pubitemid 34202038)
14. Hay ED,. 2005. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233: 706-720. (Pubitemid 40853448)
15. He F, Xiong W, Yu X, Espinoza-Lewis R, Liu C, Gu S, Nishita M, Suzuki K, Yamada G, Minami Y, Chen Y,. 2008. Wnt5a regulates directional cell migration and cell proliferation via Ror2-mediated noncanonical pathway in mammalian palate development. Development 135: 3871-3879.
16. Holladay SD, Sharova L, Smith BJ, Gogal RM, Jr., Ward DL, Blaylock BL,. 2000. Nonspeciïc stimulation of the maternal immune system. I. Effects on teratogen-induced fetal malformations. Teratology 62: 413-419.
17. Holladay SD, Sharova LV, Punareewattana K, Hrubec TC, Gogal RM, Jr., Prater MR, Sharov AA,. 2002. Maternal immune stimulation in mice decreases fetal malformations caused by teratogens. Int Immunopharmacol 2: 325-332. (Pubitemid 34075421)
18. Janz D, Fuchs U,. 1964. Are anti-epileptic drugs harmful during pregnancy ? Dtsch Med Wochenschr 89: 241-248.
19. Karolyi J, Erickson RP, Liu S, Killewald L,. 1990. Major effects on teratogen-induced facial clefting in mice determined by a single genetic region. Genetics 126: 201-205. (Pubitemid 20336285)
20. Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, Watanabe Y, Howard E, Lima RLD, Daack-Hirsch S, Sander A, McDonald-McGinn DM, Zackai EH, Lammer EJ, Aylsworth AS, Ardinger HH, Lidral AC, Pober BR, Moreno L, Arcos-Burgos M, Valencia C, Houdayer C, Bahuau M, Moretti-Ferreira D, Richieri-Costa A, Dixon MJ, Murray JC,. 2002. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet 32: 285-289.
21. Little J, Cardy A, Munger RG,. 2004. Tobacco smoking and oral clefts: A meta-analysis. Bull World Health Organ 82: 213-218. (Pubitemid 38524327)
22. Liu KJ, Arron JR, Stankunas K, Crabtree GR, Longaker MT,. 2007. Chemical rescue of cleft palate and midline defects in conditional GSK-3beta mice. Nature 446: 79-82. (Pubitemid 46348041)
23. Mahabady MK, Ranjbar R, Arzi A, Papahn AA, Najafzadeh H,. 2006. A comparison study of effects of Echinacea extract and levamisole on phenytoin-induced cleft palate in mice. Regul Toxicol Pharmacol 46: 163-166. (Pubitemid 44692905)
24. Meador KJ, Baker GA, Finnell RH, Kalayjian LA, Liporace JD, Loring DW, Mawer G, Pennell PB, Smith JC, Wolff MC, NEAD Study Group. 2006. In utero antiepileptic drug exposure: Fetal death and malformations. Neurology 67: 407-412. (Pubitemid 44214962)
25. Mishima S, Saito K, Maruyama H, Inoue M, Yamashita T, Ishida T, Gu Y,. 2004. Antioxidant and immuno-enhancing effects of Echinacea purpurea. Biol Pharm Bull 27: 1004-1009. (Pubitemid 41701749)
26. Mossey P, Castillia E,. 2003. Global registry and database on craniofacial anomalies. Geneva: World Health Organization.
27. Mossey PA, Little J, Munger RG, Dixon MJ, Shaw WC,. 2009. Cleft lip and palate. Lancet 374: 1773-1785.
28. Murray JC,. 2002. Gene/environment causes of cleft lip and/or palate. Clin Genet 61: 248-256. (Pubitemid 36372641)
29. Murray JC, Schutte BC,. 2004. Cleft palate: Players, pathways, and pursuits. J Clin Invest 113: 1676-1678. (Pubitemid 39071657)
30. Nieri P, Adinolfi B, Morelli I, Breschi MC, Simoni G, Martinotti E,. 2003. Genetic characterization of the three medicinal Echinacea species using RAPD analysis. Planta Med 69: 685-686. (Pubitemid 37041071)
31. Perry NB, Burgess EJ, Glennie VL,. 2001. Echinacea standardization: Analytical methods for phenolic compounds and typical levels in medicinal species. J Agric Food Chem 49: 1702-1706. (Pubitemid 32816807)
32. Prater MR, Zimmerman KL, Ward DL, Holladay SD,. 2004. Reduced birth defects caused by maternal immune stimulation in methylnitrosourea-exposed mice: Association with placental improvement. Birth Defects Res A Clin Mol Teratol 70: 862-869. (Pubitemid 39602197)
33. Pugh ND, Tamta H, Balachandran P, Wu X, Howell J, Dayan FE, Pasco DS,. 2008. The majority of in vitro macrophage activation exhibited by extracts of some immune enhancing botanicals is due to bacterial lipoproteins and lipopolysaccharides. Int Immunopharmacol 8: 1023-1032.
34. Rice R, Spencer-Dene B, Connor EC, Gritli-Linde A, McMahon AP, Dickson C, Thesleff I, Rice DP,. 2004. Disruption of Fgf10/Fgfr2b-coordinated epithelial-mesenchymal interactions causes cleft palate. J Clin Invest 113: 1692-1700. (Pubitemid 39071661)
35. Rininger JA, Kickner S, Chigurupati P, McLean A, Franck Z,. 2000. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. J Leukoc Biol 68: 503-510.
36. Risley M, Garrod D, Henkemeyer M, McLean W,. 2009. EphB2 and EphB3 forward signalling are required for palate development. Mech Dev 126: 230-239.
37. Roesler J, Emmendörffer A, Steinmüller C, Luettig B, Wagner H, Lohmann-Matthes ML,. 1991. Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to test subjects mediates activation of the phagocyte system. Int J Immunopharmacol 13: 931-941.
38. Sonawane BR, Goldman AS,. 1981. Susceptibility of mice to phenytoin-induced cleft palate correlated with inhibition of fetal palatal RNA and protein synthesis. Proc Soc Exp Biol Med 168: 175-179. (Pubitemid 12212450)
39. Suzuki K, Hu D, Bustos T, Zlotogora J, Richieri-Costa A, Helms JA, Spritz RA,. 2000. Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat Genet 25: 427-430. (Pubitemid 32983436)
40. Takechi R, Taniguchi A, Ebara S, Fukui T, Watanabe T,. 2008. Biotin deficiency affects the proliferation of human embryonic palate mesenchymal cells in culture. J Nutr 138: 680-684. (Pubitemid 351469409)
41. Thiery JP, Acloque H, Huang RY, Nieto MA,. 2009. Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
42. Vanhoutteghem A, Maciejewski-Duval A, Bouche C, Delhomme B, Hervé F, Daubigney F, Soubigou G, Araki M, Araki K, Yamamura K, Djian P,. 2009. Basonuclin 2 has a function in the multiplication of embryonic craniofacial mesenchymal cells and is orthologous to disco proteins. Proc Natl Acad Sci USA 106: 14432-14437.
43. Wilkie AO, Morriss-Kay GM,. 2001. Genetics of craniofacial development and malformation. Nat Rev Genet 2: 458-468. (Pubitemid 33673412)
44. Yang J, Weinberg RA,. 2008. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 14: 818-829. (Pubitemid 351757205)
45. Yano H, Yoshimoto H, Ohtsuru A, Ito M, Yamashita S, Fujii T,. 1996. Characterization of cultured rat embryonic palatal mesenchymal cells. Cleft Palate Craniofac J 33: 379-384. (Pubitemid 26327790)